Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Laryngotracheal Stenosis Using Autologous Olfactory-mucosa-derived Mesenchymal Stem Cells

NCT03130374 is registered in ClinicalTrials.gov with The Republican Research and Practical Center for Epidemiology and Microbiology as lead sponsor.

NCT NCT03130374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03130374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Laryngotracheal Stenosis Using Autologous Olfactory-mucosa-derived Mesenchymal Stem Cells
Lead sponsor
The Republican Research and Practical Center for Epidemiology and Microbiology
Phase
Phase 1/2
Overall status
Completed
Start date
January 3, 2017
Completion date
May 20, 2019
Enrollment
12 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

laryngeal stenosis, mesenchymal stem cells, tracheal stenosis